Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoic acid receptor gamma (RAR-γ), also known as NR1B3, is a member of the nuclear receptor superfamily. It functions as a ligand-dependent transcription factor, regulating gene expression by forming heterodimers with RXRs and binding to RAREs. RAR-γ plays critical roles in development, skeletal growth, cell differentiation, and other biological processes. It is a therapeutic target for conditions like acne, and mutations/rearrangements are associated with certain leukemias.
Ligand-dependent transcription factor; forms heterodimers with RXRs and binds to retinoic acid response elements (RAREs) to regulate gene expression.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoic acid receptor gamma (RAR-γ).